Twist Bioscience Corp (TWST) with a beta value of 2.38 appears to be a promising investment opportunity.

Twist Bioscience Corp (NASDAQ: TWST) on Tuesday, plunged -3.78% from the previous trading day, before settling in for the closing price of $37.8. Within the past 52 weeks, TWST’s price has moved between $27.12 and $60.90.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

During the last 5-year period, the sales growth of Healthcare Sector giant was 1.70%. The company achieved an average annual earnings per share of 40.52%. With a float of $56.69 million, this company’s outstanding shares have now reached $59.86 million.

Let’s determine the extent of company efficiency that accounts for 923 employees. In terms of profitability, gross margin is 46.7%, operating margin of -57.86%, and the pretax margin is -55.03%.

Twist Bioscience Corp (TWST) Breakdown of a Key Holders of the stock

Observing investor behavior towards Diagnostics & Research industry stocks is more important than anything else. The insider ownership of Twist Bioscience Corp is 5.38%, while institutional ownership is 109.97%. The most recent insider transaction that took place on Jul 09 ’25, was worth 93,420. In this transaction Chief Financial Officer of this company sold 2,449 shares at a rate of $38.15, taking the stock ownership to the 103,569 shares. Before that another transaction happened on Jul 09 ’25, when Company’s Officer proposed sale 2,449 for $38.15, making the entire transaction worth $93,419.

Twist Bioscience Corp (TWST) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around 40.52% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 37.99% during the next five years compared to 1.70% growth over the previous five years of trading.

Twist Bioscience Corp (NASDAQ: TWST) Trading Performance Indicators

Twist Bioscience Corp (TWST) is currently performing well based on its current performance indicators. A quick ratio of 4.24 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 6.27.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.26, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -1.35 in one year’s time.

Technical Analysis of Twist Bioscience Corp (TWST)

Looking closely at Twist Bioscience Corp (NASDAQ: TWST), its last 5-days average volume was 0.95 million, which is a drop from its year-to-date volume of 1.1 million. As of the previous 9 days, the stock’s Stochastic %D was 49.87%.

During the past 100 days, Twist Bioscience Corp’s (TWST) raw stochastic average was set at 43.10%, which indicates a significant increase from 33.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.83 in the past 14 days, which was lower than the 2.51 volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $33.57, while its 200-day Moving Average is $41.48. However, in the short run, Twist Bioscience Corp’s stock first resistance to watch stands at $38.01. Second resistance stands at $39.65. The third major resistance level sits at $40.70. If the price goes on to break the first support level at $35.32, it is likely to go to the next support level at $34.27. Now, if the price goes above the second support level, the third support stands at $32.63.

Twist Bioscience Corp (NASDAQ: TWST) Key Stats

Market capitalization of the company is 2.18 billion based on 59,916K outstanding shares. Right now, sales total 312,970 K and income totals -208,730 K. The company made 92,790 K in profit during its latest quarter, and -39,330 K in sales during its previous quarter.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.